Table 4. Predictive clinical factors associated with the risk of internal fistula in Korean patients with Crohn’s disease.
Univariate analysis a | Multivariate analysis b | |||||
---|---|---|---|---|---|---|
5-year cumulative rate (%) | P value | HR | 95% CI | P value | ||
Age at diagnosis (%) | 0.354 | |||||
< 40 years | 13.2 | 1.34 | 0.84–2.15 | 0.221 | ||
≥ 40 years | 12.7 | 1 (Ref) | ||||
Gender | 0.211 | |||||
Male | 12.5 | 0.81 | 0.59–1.12 | 0.207 | ||
Female | 14.9 | 1 (Ref) | ||||
Family history of IBD (%) | 0.893 | |||||
Yes | 8.7 | 0.89 | 0.33–2.41 | 0.818 | ||
No | 13.3 | 1 (Ref) | ||||
Disease location at diagnosis (%) c | 0.009 | |||||
Any ileal involvement | 14.2 | 1.89 | 1.17–3.06 | 0.009 | ||
No involvement of ileum | 8.5 | 1 (Ref) | ||||
Concomitant UGI disease (L4) | 0.829 | |||||
Yes | 14.2 | 0.99 | 0.59–1.66 | 0.958 | ||
No | 13.1 | 1 (Ref) | ||||
Interval of diagnostic delay (%) | 0.040 | |||||
< 3 months | 11.7 | 1 (Ref) | ||||
3–6 months | 12.5 | 1.01 | 0.63–1.64 | 0.957 | ||
6–18 months | 10.2 | 0.92 | 0.59–1.43 | 0.720 | ||
≥ 18 months | 19.4 | 1.62 | 1.12–2.33 | 0.011 |
HR, hazard ratio; CI, confidence interval; IBD, inflammatory bowel disease; UGI, upper gastrointestinal.
acalculated by a Kaplan-Meier survival model.
banalyzed by a multivariate Cox proportional hazards regression model.
cDisease location and behavior were determined according to the Montreal classification.